Official Title

A Prospective, Randomized, Double-Blind, Sham-Controlled, Multi-Center Pivotal Study to Evaluate the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita® System in Subjects with Type 2 Diabetes on Insulin therapy.

Study Details

This study will learn more about the use of the Fractyl Revita® System for the treatment of type 2 diabetes for patients on insulin therapy.

Principal Investigator

Dr. Julie Silverstein

IRB Number



1. Participant must be 18 to 70 years old
2. Participants must have type 2 diabetes
3. Participants must require insulin therapy to treat their diabetes

Volunteer Information

For more information about this study, contact Volunteer for Health at: